Dr Rachel Shaw is a co-founder and CEO of Eden Bio, a UK biotech start up using machine learning to revolutionise microorganism-based protein production through maximising protein productivity. Within a year of launching, Eden Bio raised £1M and successfully delivered on its first commercial contracts. Prior to leading Eden Bio, Rachel worked for the world’s largest independent funder of cancer research, bringing in and stewarding key partnerships, high-value donations worth up to £40M and representing the company for mass fundraising through a range of media, including live telethons. Rachel also has a PhD from King’s College London and has published three books.